Stenabolic 10 mg, 60 caps

Stenabolic (SR9009) – 10 mg, 60 Capsules

Chemical Name: SR9009
Molecular Formula: C₂₀H₂₄ClN₃O₄S
Compound Class: Rev-ErbAα Agonist / Metabolic Modulator

Product Overview

Stenabolic, also known as SR9009, is a cutting-edge compound developed by The Scripps Research Institute, designed to modulate circadian rhythms, enhance metabolic activity, and improve endurance by targeting the Rev-ErbAα nuclear receptor. Unlike SARMs, Stenabolic is not an androgen receptor modulator but rather a metabolic modulator, often referred to as “exercise in a pill” due to its effects on stamina, fat oxidation, and energy expenditure in preclinical models.

Each capsule contains 10 mg of pure SR9009, with 60 capsules per bottle, offering a highly convenient dosing format for ongoing research studies.

Mechanism of Action

Stenabolic works by activating the Rev-ErbAα receptor, a key regulator of mitochondrial function, lipid metabolism, and circadian rhythm. Through this pathway, SR9009 enhances:

• Mitochondrial biogenesis

• Glucose and lipid metabolism

• Fat oxidation

• Muscle endurance and energy utilization

Unlike traditional stimulants or anabolic compounds, Stenabolic does not affect hormone levels or bind to androgen receptors, making it ideal for research focused on endurance, fat loss, and metabolic health without hormonal interference.

Research Highlights

Though not officially approved as a drug or dietary supplement, SR9009 has been widely studied in preclinical animal models, where it has shown promise in:

• Increasing oxygen consumption and metabolic rate

• Improving endurance and running capacity

• Reducing body fat without altering diet

• Enhancing muscle mitochondrial function

• Lowering plasma triglycerides, cholesterol, and inflammation markers

These findings make Stenabolic a unique candidate in the field of metabolic disease research, weight management, and performance science.